Copyright: ©Author(s) 2026.
World J Diabetes. Oct 15, 2026; 17(10): 125355
Published online Oct 15, 2026. doi: 10.4239/wjd.125355
Published online Oct 15, 2026. doi: 10.4239/wjd.125355
Table 1 Comparison of baseline clinical characteristics in type 2 diabetes mellitus patients, n (%)/mean ± SD
| Variables | Total (n = 648) | Non-MASLD (n = 380) | MASLD (n = 260) | P value |
| Age (year) | 57.19 ± 13.07 | 60.68 ± 11.79 | 52.25 ± 13.23 | < 0.001 |
| Duration (year) | 5.00 (2.00, 14.00) | 8.00 (2.75, 15.00) | 3.00 (1.00, 9.25) | < 0.001 |
| SBP (mmHg) | 139.68 ± 18.44 | 139.37 ± 19.41 | 140.10 ± 16.98 | 0.611 |
| DBP (mmHg) | 82.89 ± 12.36 | 80.77 ± 11.96 | 85.88 ± 12.31 | < 0.001 |
| BMI (kg/m2) | 26.41 ± 4.51 | 25.11 ± 3.76 | 28.26 ± 4.84 | < 0.001 |
| WC (cm) | 96.44 ± 12.15 | 93.33 ± 11.16 | 100.85 ± 12.16 | < 0.001 |
| HC (cm) | 102.25 ± 10.28 | 99.88 ± 8.95 | 105.60 ± 11.09 | < 0.001 |
| LDL-C (mmol/L) | 3.09 ± 0.94 | 3.03 ± 0.92 | 3.19 ± 0.96 | 0.034 |
| HDL-C (mmol/L) | 1.23 ± 0.30 | 1.26 ± 0.29 | 1.19 ± 0.31 | 0.003 |
| TG (mmol/L) | 2.20 ± 2.65 | 1.81 ± 2.28 | 2.74 ± 3.03 | < 0.001 |
| TC (mmol/L) | 4.95 ± 1.38 | 4.80 ± 1.29 | 5.17 ± 1.48 | 0.001 |
| ALT (U/L) | 23.00 (16.00, 35.00) | 19.00 (14.00, 28.25) | 29.00 (20.00, 45.00) | < 0.001 |
| AST (U/L) | 19.00 (15.00, 26.00) | 17.00 (14.00, 22.00) | 22.00 (17.00, 33.00) | < 0.001 |
| FBG (mmol/L) | 9.37 ± 3.36 | 9.14 ± 3.51 | 9.69 ± 3.11 | 0.043 |
| HbA1c (%) | 8.64 ± 2.06 | 8.58 ± 2.17 | 8.73 ± 1.89 | 0.367 |
| BUN (mmol/L) | 5.69 ± 2.44 | 5.77 ± 2.08 | 5.56 ± 2.87 | 0.273 |
| UA (mmol/L) | 341.55 ± 101.79 | 325.64 ± 95.85 | 364.10 ± 105.81 | < 0.001 |
| Scr (mmol/L) | 64.88 ± 24.26 | 65.53 ± 25.09 | 63.96 ± 23.05 | 0.416 |
| Hcy (μmol/L) | 14.17 ± 7.35 | 13.74 ± 6.23 | 14.76 ± 8.67 | 0.082 |
| RBC (× 1012/L) | 4.66 ± 0.58 | 4.56 ± 0.59 | 4.80 ± 0.52 | < 0.001 |
| Hb (g/L) | 142.18 ± 19.37 | 138.74 ± 19.37 | 147.05 ± 18.32 | < 0.001 |
| WBC (× 109/L) | 6.20 ± 1.86 | 5.98 ± 1.69 | 6.51 ± 2.04 | < 0.001 |
| PLT (× 109/L) | 224.57 ± 60.02 | 218.11 ± 58.58 | 233.73 ± 60.95 | 0.001 |
| eGDR | 5.85 ± 2.46 | 6.30 ± 2.43 | 5.21 ± 2.36 | < 0.001 |
| Sex | - | - | - | 0.025 |
| Male | 375 (57.87) | 206 (54.21) | 169 (63.06) | - |
| Female | 273 (42.13) | 174 (45.79) | 99 (36.94) | - |
| Smoking | - | - | - | 0.362 |
| No | 200 (30.86) | 112 (29.47) | 88 (32.84) | - |
| Yes | 448 (69.14) | 268 (70.53) | 180 (67.16) | - |
| HT | - | - | - | 0.030 |
| No | 289 (44.60) | 183 (48.16) | 106 (39.55) | - |
| Yes | 359 (55.40) | 197 (51.84) | 162 (60.45) | - |
| eGDR quantile | - | - | - | < 0.001 |
| Q1 | 162 (25.00) | 65 (17.11) | 97 (36.19) | - |
| Q2 | 162 (25.00) | 99 (26.05) | 63 (23.51) | - |
| Q3 | 162 (25.00) | 101 (26.58) | 61 (22.76) | - |
| Q4 | 162 (25.00) | 115 (30.26) | 47 (17.54) | - |
- Citation: Yin JT, Lu YX, Li ZM, Niu S. Association between estimated glucose disposal rate and metabolic dysfunction-associated steatotic liver disease in type 2 diabetes mellitus patients. World J Diabetes 2026; 17(10): 125355
- URL: https://www.wjgnet.com/1948-9358/full/v17/i10/125355.htm
- DOI: https://dx.doi.org/10.4239/wjd.125355